- Home
- ARMP vs IROQ Comparison
ARMP vs IROQ Comparison
Compare ARMP & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- IROQ
- Stock Information
- Founded
- ARMP N/A
- IROQ 1883
- Country
- ARMP United States
- IROQ United States
- Employees
- ARMP N/A
- IROQ N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- IROQ Savings Institutions
- Sector
- ARMP Health Care
- IROQ Finance
- Exchange
- ARMP Nasdaq
- IROQ Nasdaq
- Market Cap
- ARMP 80.0M
- IROQ 74.8M
- IPO Year
- ARMP N/A
- IROQ 2011
- Fundamental
- Price
- ARMP $2.06
- IROQ $24.53
- Analyst Decision
- ARMP Strong Buy
- IROQ
- Analyst Count
- ARMP 1
- IROQ 0
- Target Price
- ARMP $7.00
- IROQ N/A
- AVG Volume (30 Days)
- ARMP 13.8K
- IROQ 2.4K
- Earning Date
- ARMP 11-13-2024
- IROQ 01-28-2025
- Dividend Yield
- ARMP N/A
- IROQ 1.63%
- EPS Growth
- ARMP N/A
- IROQ N/A
- EPS
- ARMP N/A
- IROQ 0.62
- Revenue
- ARMP $5,467,000.00
- IROQ $22,441,000.00
- Revenue This Year
- ARMP $23.87
- IROQ N/A
- Revenue Next Year
- ARMP N/A
- IROQ N/A
- P/E Ratio
- ARMP N/A
- IROQ $39.32
- Revenue Growth
- ARMP 34.92
- IROQ N/A
- 52 Week Low
- ARMP $1.80
- IROQ $14.85
- 52 Week High
- ARMP $4.48
- IROQ $24.53
- Technical
- Relative Strength Index (RSI)
- ARMP 49.88
- IROQ 66.03
- Support Level
- ARMP $1.97
- IROQ $22.84
- Resistance Level
- ARMP $2.28
- IROQ $24.00
- Average True Range (ATR)
- ARMP 0.14
- IROQ 0.27
- MACD
- ARMP 0.01
- IROQ 0.08
- Stochastic Oscillator
- ARMP 54.17
- IROQ 100.00
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.